Back to Executives Lilac Biosciences Appoints Adriana Coll De Peña as Chief Executive Officer New to company · from Moderna “Dr. Coll De Peña joined Lilac from Moderna, where she was a scientist from January 2024 to September 2026”
Position
Chief Executive Officer
Biotechnology Health Care Therapeutics Description Lilac Biosciences Inc. has announced the appointment of Dr. Adriana Coll De Peña as Chief Executive Officer
A new leader at Lilac Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Lilac Biosciences raises, hires an executive or expands, scored against what you sell The decision-makers there, with verified emails Who you already know at Lilac Biosciences, from your own LinkedIn network Works inside ChatGPT and Claude. Ask who to call at Lilac Biosciences. With Fundz connected, it knows.
Watch Fundz in 1:55 1:36 1:33 Trusted by Oracle Snowflake Cloudflare LinkedIn Google Salesforce ★★★★★ 4.8/5 on G2
Location
Providence, Rhode Island, United States
About
Lilac Biosciences Inc. is a Brown University spinout based in Providence, Rhode Island, that is democratizing RNA measurement. Its mission is to create innovative products that become essential tools for RNA-based research and therapeutic discovery.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lilac Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lilac Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
Track this with Fundz
Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API , with transparent published pricing.
Recent funding rounds Funded & hiring Lender intelligence Benefits intelligence Executive moves Acquisitions 
ProvidenceBiotechnologyHealth CareTherapeutics